Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Monkeys with SIV started generating specialized immune cells that may be able to hunt down and eliminate the virus from latent cells.
Trials for HIV-positive people of a treatment using the CRISPR-Cas9 gene editing tool may be on the horizon.
Researchers infected 1-month-old primates with HIV-like virus and 30 hours later injected them with a pair of antibodies.
A key mutation protected humans against simian HIV for millennia.
It likely aided the human species’s expansion but was eventually outmatched by an evolving virus.
Researchers have made progress in developing a microbicide enema that protects against contracting HIV through anal sex.
This apparently causes immediate immune reactions that effectively fuel its replication.
In addition to possibly being a part of the HIV reservoir, fat tissue may be a source of harmful chronic inflammation among those with HIV.
Lentiviruses, the class of viruses to which HIV belongs, are estimated to have infected primates as far back as 16 million years ago.
Scientists have created a powerful molecule that blocks SIV (HIV’s simian cousin) from infecting monkeys’ immune cells and that may work as a...
A new molecule blocked a simian version of HIV from attaching to immune cells, and may work as both a long-acting treatment and a vaccine for...
HIV can apparently infect cells throughout the entire female reproductive tract, according to primate research.
The grant will help fund a Phase I clinical trial in humans.
A new HIV vaccine approach has proved highly successful at blocking SIV, HIV’s virus simian cousin, among rhesus macaques.
Very early treatment limits the size of the viral reservoir in primates infected with an HIV-like virus, but the virus still rebounds after tr...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.